Trivascular Tech Shares Jump On Endologix Acquisition Deal

By MarketWatch Pulse

Trivascular Technologies Inc. shares jumped in the extended session Monday after Endologix Inc. agreed to acquire the medical device company for $211 million in stock and cash. Trivascular shares surged 55% to $7.80, but still fell short of the transaction value of $9.10 a share. Endologix shares were flat at $13.73. Trivascular also said it expects third-quarter revenue of $9.5 million, while analysts surveyed by FactSet expect $9.3 million.

Copyright © 2015 MarketWatch, Inc.

Continue Reading Below